[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fSatJDHLKYS7AeJ6SApaSAeYGeYF_nmFzrm4nA1NwVfg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Mashhad University of Medical Sciences",[4],91,false,2,23,5733,3,48,[14,16,18,20,22,24,26,29],{"name":15,"count":8},"Pregnancy",{"name":17,"count":8},"Labor Pain",{"name":19,"count":8},"Pain",{"name":21,"count":8},"Oral Lichen Planus",{"name":23,"count":8},"Diabetic Foot Ulcers",{"name":25,"count":8},"Diabetic Wound",{"name":27,"count":28},"Myofacial Pain Syndrome",1,{"name":30,"count":28},"Nursing Student",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT05983302","Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care","2024-01-20","Platelet-Rich Plasma-Fibrin Glue",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,71,89,107,150,180,198,216,234,260,287,305,330,357,383,401,426,453,478,503,527,552,580,604,628,646,669,694,712,739,763,781,806,824,848,875,893,921,939,962,986,1009,1033,1056,1080,1105,1129,1154,1172,1196,1220,1243,1267,1290,1317,1335,1353,1371,1396,1423,1441],{"intervention":36,"totalTrials":28,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":67,"NA":69},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":28,"soonestReadout":35},[56],{"nctId":33,"briefTitle":34,"status":57,"phases":58,"primaryCompletion":35,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":64},"ACTIVE_NOT_RECRUITING",[40,41],"2027-03-20","2023-08-20",40,[63],"Wounds and Injuries",[36,65,66],"Repairing Gel","Repairing Gel and Platelet-Rich Plasma-Fibrin Glue",{"trials":68,"activeCount":49},[],{"trials":70,"activeCount":49},[],{"intervention":65,"totalTrials":28,"cells":72},{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":85,"NA":87},{"trials":74,"activeCount":49},[],{"trials":76,"activeCount":49},[],{"trials":78,"activeCount":49},[],{"trials":80,"activeCount":28,"soonestReadout":35},[81],{"nctId":33,"briefTitle":34,"status":57,"phases":82,"primaryCompletion":35,"completion":59,"start":60,"enrollment":61,"conditions":83,"interventions":84},[40,41],[63],[36,65,66],{"trials":86,"activeCount":49},[],{"trials":88,"activeCount":49},[],{"intervention":66,"totalTrials":28,"cells":90},{"EARLY_PHASE1":91,"PHASE1":93,"PHASE2":95,"PHASE3":97,"PHASE4":103,"NA":105},{"trials":92,"activeCount":49},[],{"trials":94,"activeCount":49},[],{"trials":96,"activeCount":49},[],{"trials":98,"activeCount":28,"soonestReadout":35},[99],{"nctId":33,"briefTitle":34,"status":57,"phases":100,"primaryCompletion":35,"completion":59,"start":60,"enrollment":61,"conditions":101,"interventions":102},[40,41],[63],[36,65,66],{"trials":104,"activeCount":49},[],{"trials":106,"activeCount":49},[],{"intervention":108,"totalTrials":8,"cells":109},"Normal saline",{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":129,"PHASE4":131,"NA":148},{"trials":111,"activeCount":49},[],{"trials":113,"activeCount":49},[],{"trials":115,"activeCount":49},[116],{"nctId":117,"briefTitle":118,"status":119,"phases":120,"primaryCompletion":121,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},"NCT03700424","Inflammation Reduction by TREhalose AdminisTration","UNKNOWN",[40],"2022-05-20","2022-08","2020-08-20",15,[126],"Acute Coronary Syndrome",[128,108],"Trehalose",{"trials":130,"activeCount":49},[],{"trials":132,"activeCount":49},[133],{"nctId":134,"briefTitle":135,"status":119,"phases":136,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":145},"NCT02032394","Effect of Chlorhexidine on Bacteriuria",[42],"2014-02","2014-04","2013-07",105,[142,143,144],"Urinary Tract Infection","Nosocomial Infection","Bacteriuria",[146,147,108],"Povidone-iodine","Chlorhexidine",{"trials":149,"activeCount":49},[],{"intervention":151,"totalTrials":28,"cells":152},"Nicorandil",{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":178},{"trials":154,"activeCount":49},[],{"trials":156,"activeCount":49},[],{"trials":158,"activeCount":49},[],{"trials":160,"activeCount":49},[],{"trials":162,"activeCount":49},[163],{"nctId":164,"briefTitle":165,"status":166,"phases":167,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":176},"NCT02254252","Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow","COMPLETED",[42],"2013-03","2013-06","2012-03",54,[173,174,175],"Slow Coronary Flow","Normal, or Near Normal Coronary Angiography","Stable Angina",[151,177],"Nitroglycerin",{"trials":179,"activeCount":49},[],{"intervention":177,"totalTrials":28,"cells":181},{"EARLY_PHASE1":182,"PHASE1":184,"PHASE2":186,"PHASE3":188,"PHASE4":190,"NA":196},{"trials":183,"activeCount":49},[],{"trials":185,"activeCount":49},[],{"trials":187,"activeCount":49},[],{"trials":189,"activeCount":49},[],{"trials":191,"activeCount":49},[192],{"nctId":164,"briefTitle":165,"status":166,"phases":193,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":194,"interventions":195},[42],[173,174,175],[151,177],{"trials":197,"activeCount":49},[],{"intervention":146,"totalTrials":28,"cells":199},{"EARLY_PHASE1":200,"PHASE1":202,"PHASE2":204,"PHASE3":206,"PHASE4":208,"NA":214},{"trials":201,"activeCount":49},[],{"trials":203,"activeCount":49},[],{"trials":205,"activeCount":49},[],{"trials":207,"activeCount":49},[],{"trials":209,"activeCount":49},[210],{"nctId":134,"briefTitle":135,"status":119,"phases":211,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":212,"interventions":213},[42],[142,143,144],[146,147,108],{"trials":215,"activeCount":49},[],{"intervention":147,"totalTrials":28,"cells":217},{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":224,"PHASE4":226,"NA":232},{"trials":219,"activeCount":49},[],{"trials":221,"activeCount":49},[],{"trials":223,"activeCount":49},[],{"trials":225,"activeCount":49},[],{"trials":227,"activeCount":49},[228],{"nctId":134,"briefTitle":135,"status":119,"phases":229,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":230,"interventions":231},[42],[142,143,144],[146,147,108],{"trials":233,"activeCount":49},[],{"intervention":235,"totalTrials":28,"cells":236},"Rituximab",{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":243,"PHASE4":245,"NA":258},{"trials":238,"activeCount":49},[],{"trials":240,"activeCount":49},[],{"trials":242,"activeCount":49},[],{"trials":244,"activeCount":49},[],{"trials":246,"activeCount":49},[247],{"nctId":248,"briefTitle":249,"status":166,"phases":250,"primaryCompletion":251,"completion":252,"start":253,"enrollment":254,"conditions":255,"interventions":257},"NCT01593332","Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis",[42],"2011-09","2011-10","2010-07",44,[256],"DMARD Resistant Rheumatoid Arthritis",[235,235],{"trials":259,"activeCount":49},[],{"intervention":261,"totalTrials":28,"cells":262},"Formocresol",{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":285},{"trials":264,"activeCount":49},[],{"trials":266,"activeCount":49},[],{"trials":268,"activeCount":49},[],{"trials":270,"activeCount":49},[],{"trials":272,"activeCount":49},[273],{"nctId":274,"briefTitle":275,"status":119,"phases":276,"primaryCompletion":277,"start":137,"enrollment":278,"conditions":279,"interventions":283},"NCT02286648","Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars",[42],"2015-07",50,[280,281,282],"Pulpitis","Dental Pulp Disease","Tooth Diseases",[261,284],"Mineral Trioxide Aggregate",{"trials":286,"activeCount":49},[],{"intervention":284,"totalTrials":28,"cells":288},{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":303},{"trials":290,"activeCount":49},[],{"trials":292,"activeCount":49},[],{"trials":294,"activeCount":49},[],{"trials":296,"activeCount":49},[],{"trials":298,"activeCount":49},[299],{"nctId":274,"briefTitle":275,"status":119,"phases":300,"primaryCompletion":277,"start":137,"enrollment":278,"conditions":301,"interventions":302},[42],[280,281,282],[261,284],{"trials":304,"activeCount":49},[],{"intervention":306,"totalTrials":28,"cells":307},"Leflunomide",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":328},{"trials":309,"activeCount":49},[],{"trials":311,"activeCount":49},[],{"trials":313,"activeCount":49},[],{"trials":315,"activeCount":49},[],{"trials":317,"activeCount":49},[318],{"nctId":319,"briefTitle":320,"status":119,"phases":321,"primaryCompletion":322,"completion":323,"start":169,"enrollment":324,"conditions":325,"interventions":327},"NCT02024334","Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis",[42],"2014-06","2014-12",30,[326],"Juvenile Idiopathic Arthritis",[306],{"trials":329,"activeCount":49},[],{"intervention":331,"totalTrials":28,"cells":332},"Temozolomide",{"EARLY_PHASE1":333,"PHASE1":335,"PHASE2":337,"PHASE3":339,"PHASE4":353,"NA":355},{"trials":334,"activeCount":49},[],{"trials":336,"activeCount":49},[],{"trials":338,"activeCount":49},[],{"trials":340,"activeCount":49},[341],{"nctId":342,"briefTitle":343,"status":119,"phases":344,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":349,"interventions":352},"NCT03633552","Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma",[41],"2021-03-03","2021-04-03","2018-03-03",62,[350,351],"Glioblastoma Multiforme of Brain","Anaplastic Astrocytoma of Brain",[331],{"trials":354,"activeCount":49},[],{"trials":356,"activeCount":49},[],{"intervention":358,"totalTrials":28,"cells":359},"Hyoscine",{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":379,"NA":381},{"trials":361,"activeCount":49},[],{"trials":363,"activeCount":49},[],{"trials":365,"activeCount":49},[],{"trials":367,"activeCount":49},[368],{"nctId":369,"briefTitle":370,"status":166,"phases":371,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":377},"NCT01644838","Effect of Hyoscine and Promethazine on Labor Pain",[40,41],"2011-03","2011-04","2010-08",93,[17],[358,378],"Promethazine",{"trials":380,"activeCount":49},[],{"trials":382,"activeCount":49},[],{"intervention":378,"totalTrials":28,"cells":384},{"EARLY_PHASE1":385,"PHASE1":387,"PHASE2":389,"PHASE3":391,"PHASE4":397,"NA":399},{"trials":386,"activeCount":49},[],{"trials":388,"activeCount":49},[],{"trials":390,"activeCount":49},[],{"trials":392,"activeCount":49},[393],{"nctId":369,"briefTitle":370,"status":166,"phases":394,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":395,"interventions":396},[40,41],[17],[358,378],{"trials":398,"activeCount":49},[],{"trials":400,"activeCount":49},[],{"intervention":402,"totalTrials":28,"cells":403},"Thiamine",{"EARLY_PHASE1":404,"PHASE1":406,"PHASE2":408,"PHASE3":410,"PHASE4":422,"NA":424},{"trials":405,"activeCount":49},[],{"trials":407,"activeCount":49},[],{"trials":409,"activeCount":49},[],{"trials":411,"activeCount":49},[412],{"nctId":413,"briefTitle":414,"status":166,"phases":415,"primaryCompletion":416,"completion":417,"start":418,"enrollment":278,"conditions":419,"interventions":421},"NCT01115504","Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy",[41],"2010-11","2010-12","2010-05",[420],"Chronic Heart Failure",[402],{"trials":423,"activeCount":49},[],{"trials":425,"activeCount":49},[],{"intervention":427,"totalTrials":28,"cells":428},"Fentanyl",{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":449,"NA":451},{"trials":430,"activeCount":49},[],{"trials":432,"activeCount":49},[],{"trials":434,"activeCount":49},[],{"trials":436,"activeCount":49},[437],{"nctId":438,"briefTitle":439,"status":440,"phases":441,"primaryCompletion":442,"completion":443,"start":444,"enrollment":445,"conditions":446,"interventions":448},"NCT01648595","Effect of Fentanyl on Pain Severity and Duration of Labor","TERMINATED",[40,41],"2006-08","2006-09","2006-01",70,[447],"Decrease Labor Pain",[427],{"trials":450,"activeCount":49},[],{"trials":452,"activeCount":49},[],{"intervention":454,"totalTrials":28,"cells":455},"Lidocaine",{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":460,"PHASE3":462,"PHASE4":474,"NA":476},{"trials":457,"activeCount":49},[],{"trials":459,"activeCount":49},[],{"trials":461,"activeCount":49},[],{"trials":463,"activeCount":49},[464],{"nctId":465,"briefTitle":466,"status":166,"phases":467,"primaryCompletion":468,"completion":469,"start":470,"enrollment":324,"conditions":471,"interventions":473},"NCT01659359","The Effect of Virtual Reality Glasses on Pain and Anxiety",[40,41],"2012-07","2012-08","2011-01",[472],"Pain and Anxiety",[454],{"trials":475,"activeCount":49},[],{"trials":477,"activeCount":49},[],{"intervention":479,"totalTrials":28,"cells":480},"Crucumin",{"EARLY_PHASE1":481,"PHASE1":483,"PHASE2":485,"PHASE3":487,"PHASE4":499,"NA":501},{"trials":482,"activeCount":49},[],{"trials":484,"activeCount":49},[],{"trials":486,"activeCount":49},[],{"trials":488,"activeCount":49},[489],{"nctId":490,"briefTitle":491,"status":119,"phases":492,"primaryCompletion":493,"completion":494,"start":495,"enrollment":324,"conditions":496,"interventions":498},"NCT03715140","Crucumin Effects on the Immune System in Osteoarthritis Patients",[41],"2020-09-21","2020-12-30","2019-05-01",[497],"Osteoarthritis",[479],{"trials":500,"activeCount":49},[],{"trials":502,"activeCount":49},[],{"intervention":504,"totalTrials":28,"cells":505},"PRP-Fibrin Glue",{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":512,"PHASE4":523,"NA":525},{"trials":507,"activeCount":49},[],{"trials":509,"activeCount":49},[],{"trials":511,"activeCount":49},[],{"trials":513,"activeCount":49},[514],{"nctId":515,"briefTitle":516,"status":119,"phases":517,"primaryCompletion":518,"completion":518,"start":519,"enrollment":520,"conditions":521,"interventions":522},"NCT04315909","The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers",[40,41],"2020-06-23","2019-08-28",24,[23,25],[504],{"trials":524,"activeCount":49},[],{"trials":526,"activeCount":49},[],{"intervention":528,"totalTrials":28,"cells":529},"Crocin",{"EARLY_PHASE1":530,"PHASE1":532,"PHASE2":534,"PHASE3":536,"PHASE4":548,"NA":550},{"trials":531,"activeCount":49},[],{"trials":533,"activeCount":49},[],{"trials":535,"activeCount":49},[],{"trials":537,"activeCount":49},[538],{"nctId":539,"briefTitle":540,"status":119,"phases":541,"primaryCompletion":542,"completion":543,"start":544,"enrollment":61,"conditions":545,"interventions":547},"NCT03375814","Evaluation Effect of Crocina on The Cellular Immune Responses in Osteoarthritis Patients",[41],"2018-03-02","2018-07-30","2016-07-20",[546],"Osteoarthritis, Knee",[528],{"trials":549,"activeCount":49},[],{"trials":551,"activeCount":49},[],{"intervention":128,"totalTrials":8,"cells":553},{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":568,"PHASE3":574,"PHASE4":576,"NA":578},{"trials":555,"activeCount":49},[],{"trials":557,"activeCount":49},[558],{"nctId":559,"briefTitle":560,"status":119,"phases":561,"primaryCompletion":562,"completion":563,"start":123,"enrollment":564,"conditions":565,"interventions":567},"NCT04663854","Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)",[39],"2022-03-20","2022-08-20",20,[566],"Alzheimer Disease",[128],{"trials":569,"activeCount":49},[570],{"nctId":117,"briefTitle":118,"status":119,"phases":571,"primaryCompletion":121,"completion":122,"start":123,"enrollment":124,"conditions":572,"interventions":573},[40],[126],[128,108],{"trials":575,"activeCount":49},[],{"trials":577,"activeCount":49},[],{"trials":579,"activeCount":49},[],{"intervention":581,"totalTrials":28,"cells":582},"Carum Cravi",{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":598,"PHASE4":600,"NA":602},{"trials":584,"activeCount":49},[],{"trials":586,"activeCount":49},[],{"trials":588,"activeCount":49},[589],{"nctId":590,"briefTitle":591,"status":119,"phases":592,"primaryCompletion":593,"start":594,"enrollment":61,"conditions":595,"interventions":597},"NCT01471288","Effect of Carum Carvi on Thyroid Hormones and TSH Level",[39,40],"2011-12","2011-05",[596],"Thyroid Cancer Patients",[581],{"trials":599,"activeCount":49},[],{"trials":601,"activeCount":49},[],{"trials":603,"activeCount":49},[],{"intervention":605,"totalTrials":28,"cells":606},"Peginterferon, Ribavirin, camel milk",{"EARLY_PHASE1":607,"PHASE1":609,"PHASE2":611,"PHASE3":622,"PHASE4":624,"NA":626},{"trials":608,"activeCount":49},[],{"trials":610,"activeCount":49},[],{"trials":612,"activeCount":49},[613],{"nctId":614,"briefTitle":615,"status":166,"phases":616,"primaryCompletion":617,"completion":617,"start":322,"enrollment":61,"conditions":618,"interventions":620},"NCT02216045","Effect of Camel Milk on Chronic Hepatitis C",[40],"2015-02",[619],"Chronic Hepatitis C",[605,621],"Peginterferon, Ribavirin",{"trials":623,"activeCount":49},[],{"trials":625,"activeCount":49},[],{"trials":627,"activeCount":49},[],{"intervention":621,"totalTrials":28,"cells":629},{"EARLY_PHASE1":630,"PHASE1":632,"PHASE2":634,"PHASE3":640,"PHASE4":642,"NA":644},{"trials":631,"activeCount":49},[],{"trials":633,"activeCount":49},[],{"trials":635,"activeCount":49},[636],{"nctId":614,"briefTitle":615,"status":166,"phases":637,"primaryCompletion":617,"completion":617,"start":322,"enrollment":61,"conditions":638,"interventions":639},[40],[619],[605,621],{"trials":641,"activeCount":49},[],{"trials":643,"activeCount":49},[],{"trials":645,"activeCount":49},[],{"intervention":647,"totalTrials":28,"cells":648},"propolis",{"EARLY_PHASE1":649,"PHASE1":651,"PHASE2":653,"PHASE3":663,"PHASE4":665,"NA":667},{"trials":650,"activeCount":49},[],{"trials":652,"activeCount":49},[],{"trials":654,"activeCount":49},[655],{"nctId":656,"briefTitle":657,"status":166,"phases":658,"primaryCompletion":372,"completion":594,"start":659,"enrollment":564,"conditions":660,"interventions":662},"NCT01375088","Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers",[40],"2010-10",[661],"Radiation-induced Mucositis of Oral Mucous Membranes",[647],{"trials":664,"activeCount":49},[],{"trials":666,"activeCount":49},[],{"trials":668,"activeCount":49},[],{"intervention":670,"totalTrials":28,"cells":671},"Prednisolone",{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":676,"PHASE3":688,"PHASE4":690,"NA":692},{"trials":673,"activeCount":49},[],{"trials":675,"activeCount":49},[],{"trials":677,"activeCount":49},[678],{"nctId":679,"briefTitle":680,"status":119,"phases":681,"primaryCompletion":682,"start":683,"enrollment":324,"conditions":684,"interventions":686},"NCT00723268","Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae",[40],"2008-08","2007-05",[685],"Oral Aphthae",[670,687],"Colchicine",{"trials":689,"activeCount":49},[],{"trials":691,"activeCount":49},[],{"trials":693,"activeCount":49},[],{"intervention":687,"totalTrials":28,"cells":695},{"EARLY_PHASE1":696,"PHASE1":698,"PHASE2":700,"PHASE3":706,"PHASE4":708,"NA":710},{"trials":697,"activeCount":49},[],{"trials":699,"activeCount":49},[],{"trials":701,"activeCount":49},[702],{"nctId":679,"briefTitle":680,"status":119,"phases":703,"primaryCompletion":682,"start":683,"enrollment":324,"conditions":704,"interventions":705},[40],[685],[670,687],{"trials":707,"activeCount":49},[],{"trials":709,"activeCount":49},[],{"trials":711,"activeCount":49},[],{"intervention":713,"totalTrials":28,"cells":714},"Helicobacter pylori eradication therapy",{"EARLY_PHASE1":715,"PHASE1":717,"PHASE2":719,"PHASE3":733,"PHASE4":735,"NA":737},{"trials":716,"activeCount":49},[],{"trials":718,"activeCount":49},[],{"trials":720,"activeCount":49},[721],{"nctId":722,"briefTitle":723,"status":166,"phases":724,"primaryCompletion":725,"completion":726,"start":727,"enrollment":728,"conditions":729,"interventions":732},"NCT06973889","Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients",[40],"2024-12-30","2025-01-21","2023-12-04",60,[730,731],"HELICOBACTER PYLORI INFECTIONS","Gastrointestinal Disease",[713],{"trials":734,"activeCount":49},[],{"trials":736,"activeCount":49},[],{"trials":738,"activeCount":49},[],{"intervention":740,"totalTrials":28,"cells":741},"Cyclosporine",{"EARLY_PHASE1":742,"PHASE1":744,"PHASE2":746,"PHASE3":757,"PHASE4":759,"NA":761},{"trials":743,"activeCount":49},[],{"trials":745,"activeCount":49},[],{"trials":747,"activeCount":49},[748],{"nctId":749,"briefTitle":750,"status":166,"phases":751,"primaryCompletion":752,"completion":617,"start":138,"enrollment":61,"conditions":753,"interventions":755},"NCT02114073","Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure",[40],"2014-11",[754],"Glaucoma, Open Angle",[740,756],"Betamethasone",{"trials":758,"activeCount":49},[],{"trials":760,"activeCount":49},[],{"trials":762,"activeCount":49},[],{"intervention":756,"totalTrials":28,"cells":764},{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":769,"PHASE3":775,"PHASE4":777,"NA":779},{"trials":766,"activeCount":49},[],{"trials":768,"activeCount":49},[],{"trials":770,"activeCount":49},[771],{"nctId":749,"briefTitle":750,"status":166,"phases":772,"primaryCompletion":752,"completion":617,"start":138,"enrollment":61,"conditions":773,"interventions":774},[40],[754],[740,756],{"trials":776,"activeCount":49},[],{"trials":778,"activeCount":49},[],{"trials":780,"activeCount":49},[],{"intervention":782,"totalTrials":28,"cells":783},"Pimecrolimus ointment",{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":800,"PHASE4":802,"NA":804},{"trials":785,"activeCount":49},[],{"trials":787,"activeCount":49},[],{"trials":789,"activeCount":49},[790],{"nctId":791,"briefTitle":792,"status":119,"phases":793,"primaryCompletion":794,"completion":795,"start":796,"enrollment":61,"conditions":797,"interventions":798},"NCT01524744","A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus",[40],"2012-10","2012-12","2009-03",[21],[782,799],"Adcortyl",{"trials":801,"activeCount":49},[],{"trials":803,"activeCount":49},[],{"trials":805,"activeCount":49},[],{"intervention":799,"totalTrials":28,"cells":807},{"EARLY_PHASE1":808,"PHASE1":810,"PHASE2":812,"PHASE3":818,"PHASE4":820,"NA":822},{"trials":809,"activeCount":49},[],{"trials":811,"activeCount":49},[],{"trials":813,"activeCount":49},[814],{"nctId":791,"briefTitle":792,"status":119,"phases":815,"primaryCompletion":794,"completion":795,"start":796,"enrollment":61,"conditions":816,"interventions":817},[40],[21],[782,799],{"trials":819,"activeCount":49},[],{"trials":821,"activeCount":49},[],{"trials":823,"activeCount":49},[],{"intervention":825,"totalTrials":28,"cells":826},"oral quercetin",{"EARLY_PHASE1":827,"PHASE1":829,"PHASE2":831,"PHASE3":842,"PHASE4":844,"NA":846},{"trials":828,"activeCount":49},[],{"trials":830,"activeCount":49},[],{"trials":832,"activeCount":49},[833],{"nctId":834,"briefTitle":835,"status":166,"phases":836,"primaryCompletion":252,"completion":837,"start":838,"enrollment":564,"conditions":839,"interventions":841},"NCT01732393","Effect of Quercetin in Prevention and Treatment of Oral Mucositis",[39,40],"2012-01","2010-01",[840],"Chemotherapy Induced Oral Mucositis",[825],{"trials":843,"activeCount":49},[],{"trials":845,"activeCount":49},[],{"trials":847,"activeCount":49},[],{"intervention":849,"totalTrials":28,"cells":850},"Enoxaparin Sodium 40 MG\u002F0.2 ML Subcutaneous Injectable",{"EARLY_PHASE1":851,"PHASE1":853,"PHASE2":855,"PHASE3":869,"PHASE4":871,"NA":873},{"trials":852,"activeCount":49},[],{"trials":854,"activeCount":49},[],{"trials":856,"activeCount":49},[857],{"nctId":858,"briefTitle":859,"status":119,"phases":860,"primaryCompletion":861,"completion":862,"start":863,"enrollment":864,"conditions":865,"interventions":867},"NCT03254511","Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer",[40],"2017-12-30","2018-12-30","2016-07-22",100,[866],"Esophageal Neoplasms",[849,868],"Chemotherapeutic Combinations",{"trials":870,"activeCount":49},[],{"trials":872,"activeCount":49},[],{"trials":874,"activeCount":49},[],{"intervention":868,"totalTrials":28,"cells":876},{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":887,"PHASE4":889,"NA":891},{"trials":878,"activeCount":49},[],{"trials":880,"activeCount":49},[],{"trials":882,"activeCount":49},[883],{"nctId":858,"briefTitle":859,"status":119,"phases":884,"primaryCompletion":861,"completion":862,"start":863,"enrollment":864,"conditions":885,"interventions":886},[40],[866],[849,868],{"trials":888,"activeCount":49},[],{"trials":890,"activeCount":49},[],{"trials":892,"activeCount":49},[],{"intervention":894,"totalTrials":28,"cells":895},"Persumac",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":915,"PHASE4":917,"NA":919},{"trials":897,"activeCount":49},[],{"trials":899,"activeCount":49},[],{"trials":901,"activeCount":49},[902],{"nctId":903,"briefTitle":904,"status":166,"phases":905,"primaryCompletion":906,"completion":907,"start":908,"enrollment":909,"conditions":910,"interventions":913},"NCT02787707","Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting",[40],"2016-04","2016-05","2015-10",69,[911,912],"Nausea","Vomiting",[894,914],"lactose",{"trials":916,"activeCount":49},[],{"trials":918,"activeCount":49},[],{"trials":920,"activeCount":49},[],{"intervention":914,"totalTrials":28,"cells":922},{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":933,"PHASE4":935,"NA":937},{"trials":924,"activeCount":49},[],{"trials":926,"activeCount":49},[],{"trials":928,"activeCount":49},[929],{"nctId":903,"briefTitle":904,"status":166,"phases":930,"primaryCompletion":906,"completion":907,"start":908,"enrollment":909,"conditions":931,"interventions":932},[40],[911,912],[894,914],{"trials":934,"activeCount":49},[],{"trials":936,"activeCount":49},[],{"trials":938,"activeCount":49},[],{"intervention":940,"totalTrials":28,"cells":941},"metronidazole,doxycycline",{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":946,"PHASE3":956,"PHASE4":958,"NA":960},{"trials":943,"activeCount":49},[],{"trials":945,"activeCount":49},[],{"trials":947,"activeCount":49},[948],{"nctId":949,"briefTitle":950,"status":166,"phases":951,"completion":952,"start":953,"enrollment":564,"conditions":954,"interventions":955},"NCT00484250","Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other",[40],"2006-05","2005-09",[21],[940],{"trials":957,"activeCount":49},[],{"trials":959,"activeCount":49},[],{"trials":961,"activeCount":49},[],{"intervention":963,"totalTrials":28,"cells":964},"orally administered cedar honey",{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":969,"PHASE3":980,"PHASE4":982,"NA":984},{"trials":966,"activeCount":49},[],{"trials":968,"activeCount":49},[],{"trials":970,"activeCount":49},[971],{"nctId":972,"briefTitle":973,"status":166,"phases":974,"primaryCompletion":975,"completion":795,"start":251,"enrollment":976,"conditions":977,"interventions":979},"NCT01974414","Cedar Honey in Oral Lichen Planus",[39,40],"2012-09",36,[978],"Erosive and Atrophic Oral Lichen Planus",[963],{"trials":981,"activeCount":49},[],{"trials":983,"activeCount":49},[],{"trials":985,"activeCount":49},[],{"intervention":987,"totalTrials":28,"cells":988},"Curcumin",{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":1001,"PHASE3":1003,"PHASE4":1005,"NA":1007},{"trials":990,"activeCount":49},[],{"trials":992,"activeCount":49},[993],{"nctId":994,"briefTitle":995,"status":119,"phases":996,"primaryCompletion":468,"completion":469,"start":997,"enrollment":324,"conditions":998,"interventions":1000},"NCT01344291","Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients",[39],"2011-07",[999],"Hyperprolactinoma",[987],{"trials":1002,"activeCount":49},[],{"trials":1004,"activeCount":49},[],{"trials":1006,"activeCount":49},[],{"trials":1008,"activeCount":49},[],{"intervention":1010,"totalTrials":28,"cells":1011},"Quercetin",{"EARLY_PHASE1":1012,"PHASE1":1014,"PHASE2":1025,"PHASE3":1027,"PHASE4":1029,"NA":1031},{"trials":1013,"activeCount":49},[],{"trials":1015,"activeCount":49},[1016],{"nctId":1017,"briefTitle":1018,"status":119,"phases":1019,"primaryCompletion":251,"completion":251,"start":1020,"enrollment":324,"conditions":1021,"interventions":1024},"NCT01375101","Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus",[39],"2010-04",[1022,1023],"Atrophic Oral Lichen Planus","Erosive Oral Lichen Planus",[1010],{"trials":1026,"activeCount":49},[],{"trials":1028,"activeCount":49},[],{"trials":1030,"activeCount":49},[],{"trials":1032,"activeCount":49},[],{"intervention":1034,"totalTrials":28,"cells":1035},"chamomilla tincture mouthwash",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1048,"PHASE3":1050,"PHASE4":1052,"NA":1054},{"trials":1037,"activeCount":49},[],{"trials":1039,"activeCount":49},[1040],{"nctId":1041,"briefTitle":1042,"status":166,"phases":1043,"primaryCompletion":1044,"completion":1044,"start":1020,"enrollment":324,"conditions":1045,"interventions":1047},"NCT01122147","Clinical Evaluation of Fluid Extract of Chamomilla Tincture for Oral Aphthae",[39],"2011-02",[1046],"Recurrent Aphthous Stomatitis",[1034],{"trials":1049,"activeCount":49},[],{"trials":1051,"activeCount":49},[],{"trials":1053,"activeCount":49},[],{"trials":1055,"activeCount":49},[],{"intervention":1057,"totalTrials":28,"cells":1058},"MCN",{"EARLY_PHASE1":1059,"PHASE1":1061,"PHASE2":1072,"PHASE3":1074,"PHASE4":1076,"NA":1078},{"trials":1060,"activeCount":49},[],{"trials":1062,"activeCount":49},[1063],{"nctId":1064,"briefTitle":1065,"status":119,"phases":1066,"primaryCompletion":1067,"completion":493,"start":1068,"enrollment":564,"conditions":1069,"interventions":1071},"NCT04370288","Clinical Application of Methylene Blue for Treatment of Covid-19 Patients",[39],"2020-09-20","2020-04-19",[1070],"Covid-19",[1057],{"trials":1073,"activeCount":49},[],{"trials":1075,"activeCount":49},[],{"trials":1077,"activeCount":49},[],{"trials":1079,"activeCount":49},[],{"intervention":1081,"totalTrials":28,"cells":1082},"Autologous mesenchymal stem cells",{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1097,"PHASE3":1099,"PHASE4":1101,"NA":1103},{"trials":1084,"activeCount":49},[],{"trials":1086,"activeCount":49},[1087],{"nctId":1088,"briefTitle":1089,"status":166,"phases":1090,"primaryCompletion":1091,"completion":1092,"start":1093,"enrollment":124,"conditions":1094,"interventions":1096},"NCT03333681","Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients",[39],"2018-08-15","2018-09-15","2016-06-20",[1095],"Rheumatoid Arthritis",[1081],{"trials":1098,"activeCount":49},[],{"trials":1100,"activeCount":49},[],{"trials":1102,"activeCount":49},[],{"trials":1104,"activeCount":49},[],{"intervention":1106,"totalTrials":28,"cells":1107},"Symbiotic",{"EARLY_PHASE1":1108,"PHASE1":1119,"PHASE2":1121,"PHASE3":1123,"PHASE4":1125,"NA":1127},{"trials":1109,"activeCount":49},[1110],{"nctId":1111,"briefTitle":1112,"status":119,"phases":1113,"primaryCompletion":795,"completion":1114,"start":251,"enrollment":1115,"conditions":1116,"interventions":1118},"NCT01413659","Evaluation of the Effect of Preoperative Symbiotic Bowel Conditioning on Surgical Site Infection After Elective Colorectal Surgery",[38],"2013-02",150,[1117],"Postoperative Wound Infection",[1106],{"trials":1120,"activeCount":49},[],{"trials":1122,"activeCount":49},[],{"trials":1124,"activeCount":49},[],{"trials":1126,"activeCount":49},[],{"trials":1128,"activeCount":49},[],{"intervention":1130,"totalTrials":28,"cells":1131},"Methylene Blue",{"EARLY_PHASE1":1132,"PHASE1":1144,"PHASE2":1146,"PHASE3":1148,"PHASE4":1150,"NA":1152},{"trials":1133,"activeCount":49},[1134],{"nctId":1135,"briefTitle":1136,"status":119,"phases":1137,"primaryCompletion":1138,"completion":1139,"start":1140,"enrollment":564,"conditions":1141,"interventions":1142},"NCT05850611","The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer",[38],"2023-08-21","2024-09-21","2023-04-30",[23,25],[1130,1143],"Methylene Blue and Platelet-Rich Plasma-Fibrin Glue",{"trials":1145,"activeCount":49},[],{"trials":1147,"activeCount":49},[],{"trials":1149,"activeCount":49},[],{"trials":1151,"activeCount":49},[],{"trials":1153,"activeCount":49},[],{"intervention":1143,"totalTrials":28,"cells":1155},{"EARLY_PHASE1":1156,"PHASE1":1162,"PHASE2":1164,"PHASE3":1166,"PHASE4":1168,"NA":1170},{"trials":1157,"activeCount":49},[1158],{"nctId":1135,"briefTitle":1136,"status":119,"phases":1159,"primaryCompletion":1138,"completion":1139,"start":1140,"enrollment":564,"conditions":1160,"interventions":1161},[38],[23,25],[1130,1143],{"trials":1163,"activeCount":49},[],{"trials":1165,"activeCount":49},[],{"trials":1167,"activeCount":49},[],{"trials":1169,"activeCount":49},[],{"trials":1171,"activeCount":49},[],{"intervention":1173,"totalTrials":28,"cells":1174},"Cabergoline",{"EARLY_PHASE1":1175,"PHASE1":1177,"PHASE2":1179,"PHASE3":1181,"PHASE4":1183,"NA":1185},{"trials":1176,"activeCount":49},[],{"trials":1178,"activeCount":49},[],{"trials":1180,"activeCount":49},[],{"trials":1182,"activeCount":49},[],{"trials":1184,"activeCount":49},[],{"trials":1186,"activeCount":49},[1187],{"nctId":1188,"briefTitle":1189,"status":119,"phases":1190,"primaryCompletion":1191,"completion":1191,"start":837,"enrollment":1192,"conditions":1193,"interventions":1195},"NCT01459601","Cabergoline Effect on Blood Sugar in Type 2 Diabetics",[43],"2012-02",10,[1194],"Diabetes Type 2",[1173],{"intervention":1197,"totalTrials":28,"cells":1198},"Metformin",{"EARLY_PHASE1":1199,"PHASE1":1201,"PHASE2":1203,"PHASE3":1205,"PHASE4":1207,"NA":1209},{"trials":1200,"activeCount":49},[],{"trials":1202,"activeCount":49},[],{"trials":1204,"activeCount":49},[],{"trials":1206,"activeCount":49},[],{"trials":1208,"activeCount":49},[],{"trials":1210,"activeCount":49},[1211],{"nctId":1212,"briefTitle":1213,"status":166,"phases":1214,"primaryCompletion":373,"completion":373,"start":1020,"enrollment":1215,"conditions":1216,"interventions":1219},"NCT01341886","Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer",[43],51,[1217,1218],"Malignant Neoplasm of Thyroid Stage I","Malignant Neoplasm of Thyroid Stage II",[1197],{"intervention":1221,"totalTrials":28,"cells":1222},"Methimazole",{"EARLY_PHASE1":1223,"PHASE1":1225,"PHASE2":1227,"PHASE3":1229,"PHASE4":1231,"NA":1233},{"trials":1224,"activeCount":49},[],{"trials":1226,"activeCount":49},[],{"trials":1228,"activeCount":49},[],{"trials":1230,"activeCount":49},[],{"trials":1232,"activeCount":49},[],{"trials":1234,"activeCount":49},[1235],{"nctId":1236,"briefTitle":1237,"status":166,"phases":1238,"primaryCompletion":837,"completion":837,"start":1239,"enrollment":1115,"conditions":1240,"interventions":1242},"NCT01560299","Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients",[43],"2010-02",[1241],"Graves Disease",[1221,1221,1221],{"intervention":1244,"totalTrials":28,"cells":1245},"Gabapentine",{"EARLY_PHASE1":1246,"PHASE1":1248,"PHASE2":1250,"PHASE3":1252,"PHASE4":1254,"NA":1256},{"trials":1247,"activeCount":49},[],{"trials":1249,"activeCount":49},[],{"trials":1251,"activeCount":49},[],{"trials":1253,"activeCount":49},[],{"trials":1255,"activeCount":49},[],{"trials":1257,"activeCount":49},[1258],{"nctId":1259,"briefTitle":1260,"status":166,"phases":1261,"primaryCompletion":1262,"completion":416,"start":1263,"enrollment":564,"conditions":1264,"interventions":1266},"NCT01255878","Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism",[43],"2010-09","2010-03",[1265],"Sleep Bruxism",[1244],{"intervention":1268,"totalTrials":28,"cells":1269},"Tissue Plasminogen Activator,bevacizumab ,follow up",{"EARLY_PHASE1":1270,"PHASE1":1272,"PHASE2":1274,"PHASE3":1276,"PHASE4":1278,"NA":1280},{"trials":1271,"activeCount":49},[],{"trials":1273,"activeCount":49},[],{"trials":1275,"activeCount":49},[],{"trials":1277,"activeCount":49},[],{"trials":1279,"activeCount":49},[],{"trials":1281,"activeCount":49},[1282],{"nctId":1283,"briefTitle":1284,"status":440,"phases":1285,"primaryCompletion":838,"completion":1263,"start":1286,"conditions":1287,"interventions":1289},"NCT01141881","Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema",[43],"2009-05",[1288],"Diabetic Macular Edema",[1268],{"intervention":1291,"totalTrials":28,"cells":1292},"Timolol",{"EARLY_PHASE1":1293,"PHASE1":1295,"PHASE2":1297,"PHASE3":1299,"PHASE4":1301,"NA":1303},{"trials":1294,"activeCount":49},[],{"trials":1296,"activeCount":49},[],{"trials":1298,"activeCount":49},[],{"trials":1300,"activeCount":49},[],{"trials":1302,"activeCount":49},[],{"trials":1304,"activeCount":49},[1305],{"nctId":1306,"briefTitle":1307,"status":166,"phases":1308,"primaryCompletion":1309,"completion":1310,"start":1191,"enrollment":445,"conditions":1311,"interventions":1313},"NCT02140450","Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection",[43],"2014-01","2014-05",[1312],"Intraocular Pressure Change in Intravitreal Injection",[1291,1314,1315,1316],"Brimonidine","Acetazolamide","Mannitol",{"intervention":1314,"totalTrials":28,"cells":1318},{"EARLY_PHASE1":1319,"PHASE1":1321,"PHASE2":1323,"PHASE3":1325,"PHASE4":1327,"NA":1329},{"trials":1320,"activeCount":49},[],{"trials":1322,"activeCount":49},[],{"trials":1324,"activeCount":49},[],{"trials":1326,"activeCount":49},[],{"trials":1328,"activeCount":49},[],{"trials":1330,"activeCount":49},[1331],{"nctId":1306,"briefTitle":1307,"status":166,"phases":1332,"primaryCompletion":1309,"completion":1310,"start":1191,"enrollment":445,"conditions":1333,"interventions":1334},[43],[1312],[1291,1314,1315,1316],{"intervention":1315,"totalTrials":28,"cells":1336},{"EARLY_PHASE1":1337,"PHASE1":1339,"PHASE2":1341,"PHASE3":1343,"PHASE4":1345,"NA":1347},{"trials":1338,"activeCount":49},[],{"trials":1340,"activeCount":49},[],{"trials":1342,"activeCount":49},[],{"trials":1344,"activeCount":49},[],{"trials":1346,"activeCount":49},[],{"trials":1348,"activeCount":49},[1349],{"nctId":1306,"briefTitle":1307,"status":166,"phases":1350,"primaryCompletion":1309,"completion":1310,"start":1191,"enrollment":445,"conditions":1351,"interventions":1352},[43],[1312],[1291,1314,1315,1316],{"intervention":1316,"totalTrials":28,"cells":1354},{"EARLY_PHASE1":1355,"PHASE1":1357,"PHASE2":1359,"PHASE3":1361,"PHASE4":1363,"NA":1365},{"trials":1356,"activeCount":49},[],{"trials":1358,"activeCount":49},[],{"trials":1360,"activeCount":49},[],{"trials":1362,"activeCount":49},[],{"trials":1364,"activeCount":49},[],{"trials":1366,"activeCount":49},[1367],{"nctId":1306,"briefTitle":1307,"status":166,"phases":1368,"primaryCompletion":1309,"completion":1310,"start":1191,"enrollment":445,"conditions":1369,"interventions":1370},[43],[1312],[1291,1314,1315,1316],{"intervention":1372,"totalTrials":28,"cells":1373},"Nitrous Oxide-Oxygen conscious sedation",{"EARLY_PHASE1":1374,"PHASE1":1376,"PHASE2":1378,"PHASE3":1380,"PHASE4":1382,"NA":1384},{"trials":1375,"activeCount":49},[],{"trials":1377,"activeCount":49},[],{"trials":1379,"activeCount":49},[],{"trials":1381,"activeCount":49},[],{"trials":1383,"activeCount":49},[],{"trials":1385,"activeCount":49},[1386],{"nctId":1387,"briefTitle":1388,"status":166,"phases":1389,"primaryCompletion":253,"start":1390,"enrollment":1391,"conditions":1392,"interventions":1395},"NCT02024594","Comparison of Effect of Nitrous Oxide-Oxygen Conscious Sedation and Cognitive-behavioral Therapy on Children's Anxiety in Dentistry",[43],"2009-10",45,[1393,1394],"Clinical Anxiety","Clinical Cooperation",[1372],{"intervention":1397,"totalTrials":28,"cells":1398},"Low dose of I-131",{"EARLY_PHASE1":1399,"PHASE1":1401,"PHASE2":1403,"PHASE3":1405,"PHASE4":1407,"NA":1409},{"trials":1400,"activeCount":49},[],{"trials":1402,"activeCount":49},[],{"trials":1404,"activeCount":49},[],{"trials":1406,"activeCount":49},[],{"trials":1408,"activeCount":49},[],{"trials":1410,"activeCount":49},[1411],{"nctId":1412,"briefTitle":1413,"status":119,"phases":1414,"primaryCompletion":323,"completion":1415,"start":1416,"enrollment":1417,"conditions":1418,"interventions":1420},"NCT02114619","Comparative Study of Different I-131 Doses in Graves' Disease",[43],"2016-12","2013-05",450,[1419],"Graves' Disease",[1397,1421,1422],"Intermediate dose","High dose",{"intervention":1421,"totalTrials":28,"cells":1424},{"EARLY_PHASE1":1425,"PHASE1":1427,"PHASE2":1429,"PHASE3":1431,"PHASE4":1433,"NA":1435},{"trials":1426,"activeCount":49},[],{"trials":1428,"activeCount":49},[],{"trials":1430,"activeCount":49},[],{"trials":1432,"activeCount":49},[],{"trials":1434,"activeCount":49},[],{"trials":1436,"activeCount":49},[1437],{"nctId":1412,"briefTitle":1413,"status":119,"phases":1438,"primaryCompletion":323,"completion":1415,"start":1416,"enrollment":1417,"conditions":1439,"interventions":1440},[43],[1419],[1397,1421,1422],{"intervention":1422,"totalTrials":28,"cells":1442},{"EARLY_PHASE1":1443,"PHASE1":1445,"PHASE2":1447,"PHASE3":1449,"PHASE4":1451,"NA":1453},{"trials":1444,"activeCount":49},[],{"trials":1446,"activeCount":49},[],{"trials":1448,"activeCount":49},[],{"trials":1450,"activeCount":49},[],{"trials":1452,"activeCount":49},[],{"trials":1454,"activeCount":49},[1455],{"nctId":1412,"briefTitle":1413,"status":119,"phases":1456,"primaryCompletion":323,"completion":1415,"start":1416,"enrollment":1417,"conditions":1457,"interventions":1458},[43],[1419],[1397,1421,1422]]